Empowering Newcomer Voices: A Trauma-Informed, Gender-Responsive Group Intervention in Schools (VOCES-NUEVAS)
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Jun 18, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called VOCES-NUEVAS, designed to support newcomer girls from Latin America who attend middle or high schools in Oakland. The program takes place in school health centers and aims to see if it is a good fit for these students and if it helps improve their mental health and overall well-being. The study will gather feedback from the girls through short surveys before and after the program, as well as after each session. Adults who lead the program will also share their thoughts to help improve the program for the future.
To join the study, girls need to be current students at an Oakland Unified School District middle or high school or its school-based health centers, speak Spanish well, and be signed up to participate in VOCES-NUEVAS during the 2024-2025 or 2025-2026 school years. The program is led by trained social workers or school staff who speak both English and Spanish and work at the participating schools. Participants can expect to take part in group sessions focused on their experiences and feelings, with opportunities to share feedback to help make the program better. This study is not yet recruiting but will help prepare for a larger study to support newcomer girls’ mental health in schools.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria (Youth):
- • current students of an Oakland Unified School District (OUSD) and/or School-based Health Center (SBHC) middle or high school site
- • Eligible and registered to participate in a VOCES NUEVAS group during the 2024-2025 or 2025-2026 school year
- Exclusion Criteria (Youth):
- • Not proficient in Spanish
- • Unable to provide informed consent or assent
- • Does not meet eligibility criteria to participate in VOCES-NUEVAS intervention
- • Not enrolled as a middle or high school at an OUSD school/SBHC site.
- Inclusion Criteria (Provider):
- • aged 18 years old or older
- • current social worker or school provider working at one of the eligible Oakland Unified School District and/or School-based Health Center middle or high school sites
- • Facilitating a VOCES NUEVAS group during the 2024-2025 or 2025-2026 school year
- • Eligible to deliver school services at OUSD school/school-based health center sites
- • Previously trained on Voices-LITE curriculum
- • proficient in English and Spanish
- Exclusion Criteria (Provider):
- • Not proficient in Spanish and/or English language
- • Not previously trained on the Voices-LITE intervention
- • Not approved to deliver the VOCES-NUEVAS intervention to students at OUSD schools/SBHC sites
- • Not leading a VOCES-NUEVAS group at an OUSD school/SBHC site during the 2024-2025 school year.
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Lauren M Haack, PhD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported